Laboratory Filtration Market

Market Definition

The market includes products and technologies used to separate solids from liquids or gases in research and analytical labs. It covers filtration methods such as vacuum, pressure, microfiltration, and ultrafiltration. These processes help in sample purification, reagent preparation, and media sterilization.

Filtration systems are vital in pharmaceutical formulation, biotechnology workflows, and environmental testing. Applications span drug development, protein isolation, cell culture, and water analysis.

The report provides a comprehensive analysis of the key drivers, emerging trends, and the competitive landscape expected to influence the market over the forecast period.

Laboratory Filtration Market Overview

The global laboratory filtration market size was valued at USD 4.13 billion in 2023 and is projected to grow from USD 4.50 billion in 2024 to USD 8.59 billion by 2031, exhibiting a CAGR of 9.69% during the forecast period.

The market is driven by advancements in pharmaceutical and biotechnology research, which demand high-performance filtration solutions for precision and reliability. Additionally, technological innovations in filtration systems, such as improved membranes and automation are enhancing efficiency and reproducibility, supporting broader adoption across research and clinical laboratories.

Major companies operating in the laboratory filtration industry are Thermo Fisher Scientific Inc., Merck KGaA, Danaher, Sartorius AG, GE Healthcare, Pall Corporation, 3M, Avantor, Inc., Asahi Kasei Corporation, Clarcor, Inc., Lenzing AG, Bio-Rad Laboratories, Inc., Advantec MFS, Inc., Koch Membrane Systems, Inc., and Filtration Group.

The market is driven by the increasing need for high-quality, purified water in research and industrial applications. Filtration technologies are essential in removing contaminants from water, ensuring compliance with quality standards in laboratories.

The growing emphasis on clean water for experiments, chemical analysis, and drug development amplifies the demand for reliable filtration systems, thus boosting the market.

• In April 2024, Asahi Kasei launched a membrane system designed to produce Water for Injection (WFI), a sterile water essential in pharmaceutical applications. This system utilizes Microza hollow-fiber membrane technology, offering an alternative to traditional distillation processes. The new system aims to enhance efficiency and reduce energy consumption in WFI production.

Key Highlights

1. The laboratory filtration industry size was valued at USD 4.13 billion in 2023.
2. The market is projected to grow at a CAGR of 9.69% from 2024 to 2031.
3. North America held a market share of 46.10% in 2023, with a valuation of USD 1.90 billion.
4. The Filtration Media segment garnered USD 1.53 billion in revenue in 2023.
5. The Microfiltration segment is expected to reach USD 3.00 billion by 2031.
6. The Pharmaceutical and Biotechnology Companies segment secured the largest revenue share of 39.34% in 2023.
7. The market in Asia Pacific is anticipated to grow at a CAGR of 10.36% during the forecast period.

Market Driver

"Advancements in Pharmaceutical and Biotechnology Research"

The laboratory filtration market registers growth, due to the expansion of pharmaceutical and biotechnology sectors. These industries rely heavily on filtration to purify reagents, samples, and biological products.

With an increasing number of drug discoveries and biotechnological advancements, the demand for filtration systems tailored to research needs continues to rise, accelerating the overall market growth.

• In May 2024, Sartorius introduced the 4th generation Sterisart Universal pump, a significant innovation in sterility testing for the pharmaceutical and biotechnology industries. This pump is designed for the reliable transfer of samples and media into Sterisart canisters, meeting the stringent quality and safety standards demanded by these sectors. Its advanced reporting software and flexible connectivity options enable laboratories to optimize operations while ensuring compliance.

Market Challenge

"High Cost of Advanced Filtration Technologies"

A significant challenge facing the growth of the laboratory filtration market is the high cost of advanced filtration systems and consumables. These costs can limit adoption, especially in academic institutions and smaller laboratories with limited budgets.

Key players are focusing on developing cost-effective filtration solutions without compromising on quality or performance. Modular designs, reusable components, and scalable systems are being introduced to reduce long-term expenses.

Additionally, some manufacturers are offering flexible financing, leasing options, and tailored service packages to help laboratories manage costs while still accessing modern, high-efficiency filtration technologies.

Market Trend

Technological Innovations in Filtration Systems

A key trend in the laboratory filtration market is the continuous advancement in filtration technologies. New filtration membranes, improved filtration media, and automation systems are enhancing the efficiency, reliability, and speed of filtration processes.

These innovations are helping laboratories meet the growing demands for greater precision and faster results, reflecting a shift toward more advanced and efficient filtration solutions.

• In October 2024, Gessner introduced MecNa, a revolutionary air filter media featuring a 3D nanofiber design. This innovative structure addresses the common issue of reduced lifespan due to low dust-holding capacity in current nanofiber filter media. MecNa offers enhanced durability and filtration performance, setting a new standard in air filtration technology.

Laboratory Filtration Market Report Snapshot

Segmentation	Details
By Product Type	Filtration Media, Filtration Assemblies, Filtration Accessories, Others
By Technology	Microfiltration, Ultrafiltration, Vacuum Filtration, Nano Filtration, Reverse Osmosis
By End User	Pharmaceutical and Biotechnology Companies, Hospital and Diagnostic Laboratories, Food and Beverage Companies, Academic Institutes, Academic and Research Institutes, Others
By Region	North America: U.S., Canada, Mexico
	Europe: France, UK, Spain, Germany, Italy, Russia, Rest of Europe
	Asia-Pacific: China, Japan, India, Australia, ASEAN, South Korea, Rest of Asia-Pacific
	Middle East & Africa: Turkey, U.A.E., Saudi Arabia, South Africa, Rest of Middle East & Africa
	South America: Brazil, Argentina, Rest of South America

Market Segmentation

• By Product Type (Filtration Media, Filtration Assemblies, Filtration Accessories, Others): The Filtration Media segment earned USD 1.53 billion in 2023, due to its critical role in ensuring high filtration efficiency, compatibility with a wide range of applications, and consistent demand across pharmaceutical, academic, and clinical research laboratories.
• By Technology (Microfiltration, Ultrafiltration, Vacuum Filtration, Nano Filtration, Reverse Osmosis): The Microfiltration segment held 35.07% share of the market in 2023, due to its broad application in removing particles and microorganisms while preserving sample integrity.
• By End User (Pharmaceutical and Biotechnology Companies, Hospital and Diagnostic Laboratories, Food and Beverage Companies, Academic Institutes, Academic and Research Institutes, Others): The Pharmaceutical and Biotechnology Companies segment is projected to reach USD 3.41 billion by 2031, owing to its consistent demand for high-precision filtration in drug development, quality control, and regulatory-compliant manufacturing processes.

Laboratory Filtration Market Regional Analysis

Based on region, the market has been classified into North America, Europe, Asia Pacific, Middle East & Africa, and South America.

North America laboratory filtration market share stood at around 46.10% in 2023, with a valuation of USD 1.90 billion. North America's expanding healthcare and biotechnology sectors are major contributors to the growth of the market.

The region has a large number of biotechnology firms and research organizations that rely heavily on filtration technologies for sample purification, reagent preparation, and medical testing.

Moreover, laboratories in the region are adopting filtration systems to test and monitor air, water, and soil quality. The demand for high-efficiency filtration systems for environmental analysis is growing, contributing significantly to the expansion of the market in North America.

• In January 2024, the U.S. Environmental Protection Agency (EPA) approved 93 additional alternative test procedures for analyzing contaminants in drinking water. This approval aims to enhance the efficiency and accuracy of water quality testing, supporting the growing emphasis on clean water for experiments, chemical analysis, and drug development.

The laboratory filtration industry in Asia Pacific is poised for significant growth at a robust CAGR of 10.36% over the forecast period. The food & beverage industry in Asia Pacific is expanding rapidly, driving the need for laboratory testing to ensure product quality and safety.

Filtration systems are essential in food testing laboratories to remove contaminants, purify samples, and ensure compliance with food safety regulations. With the growing demand for food safety and quality assurance, the market in Asia Pacific continues to register robust growth.

Furthermore, the rise of Contract Research Organizations (CROs) in Asia Pacific is driving the market. CROs play a critical role in outsourcing pharmaceutical and clinical research services, and they rely heavily on filtration systems for sample preparation, purification, and contamination control.

Regulatory Frameworks

• In the U.S., laboratory filtration systems must comply with FDA 21 CFR Part 211, which sets the standards for good manufacturing practices in drug production. Filtration technologies used in pharmaceutical manufacturing are also required to meet USP <1231> for water purity, ensuring safe and reliable sample preparation. Additionally, air filtration systems must adhere to ISO 16890 and EN 1822 standards for efficiency and performance.
• In Europe, laboratory filtration systems are governed by EU Regulation 2017/746 for in vitro diagnostic devices, ensuring compliance with safety and performance standards. Air filters are tested according to ISO 16890 and EN 1822 standards, which classify their efficiency for use in laboratory environments. The EU Machinery Directive 2006/42/EC further ensures that laboratory equipment, including filtration devices, is designed for safety and risk reduction.
• Japan's regulatory framework includes the Industrial Safety and Health Act, which applies to laboratory safety standards, including filtration systems. Laboratories must also follow Good Laboratory Practice (GLP) guidelines, which ensure high-quality testing procedures, including the use of advanced filtration technologies.
• In South Korea, laboratory filtration systems are regulated by the Korea Laboratory Accreditation Scheme (KOLAS), which ensures that laboratories meet international standards. The Ministry of Food and Drug Safety (MFDS) also sets regulations for laboratory equipment, ensuring that filtration systems meet safety and quality standards for medical and testing applications.

Competitive Landscape

Market players are increasingly adopting strategies focused on innovation and technological development, which are driving the market. Companies are meeting the growing demand for faster and more precise results by introducing advanced systems that improve efficiency, consistency, and speed. These efforts are helping to enhance the overall performance of laboratory filtration processes.

• In April 2025, Beckman Coulter Life Sciences, a Danaher company, introduced the OptiMATE Gradient Maker, an innovative instrument that automates the density gradient ultracentrifugation (DGUC) process. This advanced system enhances purification efficiency by up to 75%, while also improving consistency and reproducibility.

List of Key Companies in Laboratory Filtration Market:

• Thermo Fisher Scientific Inc.
• Merck KGaA
• Danaher
• Sartorius AG
• GE Healthcare
• Pall Corporation
• 3M
• Avantor, Inc.
• Asahi Kasei Corporation
• Clarcor, Inc.
• Lenzing AG
• Bio-Rad Laboratories, Inc.
• Advantec MFS, Inc.
• Koch Membrane Systems, Inc.
• Filtration Group

Recent Developments (Partnerships/Expansion)

• In January 2025, Sartorius and McMaster University launched a new bioprocessing automation lab at the university’s Faculty of Engineering in Hamilton, Ontario. This lab will function as a hub for training and development, where McMaster students and Sartorius employees, along with industry partners, will collaborate to advance bioprocess modeling, simulation, and control technologies.
• In December 2023, Pall Corporation and Tanajib, a leading petroleum services company in the GCC, expanded their Pall Arabia facility to incorporate filter coalescer manufacturing capabilities. This expansion aims to support the oil, gas, and petrochemical industries in the Kingdom of Saudi Arabia.